Aufklappen
Schliessen
Branche PharmaAktienmarkt General Standard |
|
|
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
| Leser | Medien | |
|---|---|---|---|---|
| 09.07. | Oasmia cuts ties with former executive chairman over questionable transactions | 1 | Seeking Alpha | |
► Artikel lesen | ||||
| OASMIA PHARMACEUTICAL Aktien ab 5,80 Euro handeln - Ohne versteckte Kosten! | LYNX | |||
► Artikel lesen | ||||
| 09.07. | Oasmia Pharmaceutical AB - 6-K, Report of foreign issuer | 1 | SEC Filings | |
► Artikel lesen | ||||
| 09.07. | Oasmia Pharmaceutical AB: Oasmia discontinues cooperation with former executive chairman | 5 | GlobeNewswire (Europe) | |
| Oasmia has today ended the engagement and cooperation with the former executive chairman Julian Aleksov without any further remuneration. This is done in the light of the transactions mentioned in the... ► Artikel lesen | ||||
| 08.07. | Oasmia Pharmaceutical and Xenetic Biosciences among healthcare gainers; Intra-Cellular Therapies leads the losers | 2 | Seeking Alpha | |
► Artikel lesen | ||||
| 05.07. | Mid-Day Market Update: Gold Down 2%; Oasmia Pharmaceutical Shares Spike Higher | 6 | Benzinga.com | |
► Artikel lesen | ||||
| 05.07. | Why Shares Of Micro-Cap Oncology Biotech Oasmia Are Ripping Higher | 6 | Benzinga.com | |
► Artikel lesen | ||||
| 05.07. | Oasmia Pharmaceutical AB: Oasmia and Arwidsro have solved outstanding balances and Arwidsro increases its investment in Oasmia | 37 | GlobeNewswire (Europe) | |
| Today an agreement has been made between Oasmia and its largest shareholder Arwidsro. The agreement is made to solve earlier unclear balances and to support the planned commercialization of Oasmia with... ► Artikel lesen | ||||
| 04.07. | Oasmia Pharmaceutical AB: Oasmia appoints Business Advisory Board | 7 | GlobeNewswire (Europe) | |
| Oasmia has appointed a Business Advisory Board with the aim of primarily supporting the commercialization of Apealea and evaluating development and market opportunities for the other product candidates.
The... ► Artikel lesen | ||||
| 02.07. | Oasmia Pharmaceutical AB - 6-K, Report of foreign issuer | - | SEC Filings | |
► Artikel lesen | ||||
| 02.07. | Oasmia Pharmaceutical AB: Oasmia appoints new CMO | 2 | GlobeNewswire (Europe) | |
| Nina Heldring, PhD, has today been appointed as acting CMO of Oasmia Pharmaceutical AB. Nina Heldring has 20 years of experience with pre-clinical and clinical medical research from renowned academic... ► Artikel lesen | ||||
| 02.07. | Oasmia Pharmaceutical AB: Oasmia appoints Scientific Advisory Board | 2 | GlobeNewswire (Europe) | |
| Oasmia today announces the formation of its Scientific Advisory Board with three key appointments: Professor Rolf Lewensohn, MD, PhD, Hans Grönlund, PhD and Ola Winqvist, MD, PhD.
The scientific... ► Artikel lesen | ||||
| 28.06. | Oasmia Pharmaceutical AB (publ) Year-end report for the financial year May 1, 2018 - April 30, 2019 | 5 | GlobeNewswire (Europe) | |
| EVENTS IN FOURTH QUARTER
Private placement of approximately MSEK 165 before issue expenses carried outNew Board of Directors elected at Extraordinary General Meeting on March 19New Board initiates... ► Artikel lesen | ||||
| 28.06. | Oasmia Pharmaceutical AB: The Board of Oasmia has decided to report certain transactions to the Swedish Economic Crime Authority and to appoint a special examiner | 4 | GlobeNewswire (Europe) | |
| The Board of Oasmia has decided to report certain suspicious transactions that has been made by the company during several years to the Swedish Economic Crime Authority.
In connection with... ► Artikel lesen | ||||
| 28.06. | Oasmia Pharmaceutical AB: Oasmia announces change of CEO | 13 | GlobeNewswire (Europe) | |
| Sven Rohmann, MD PhD MBA, has today been appointed as acting CEO of Oasmia Pharmaceutical AB. He assumes his new role July 1, 2019. Since March 2019 Sven Rohmann has been a member of the Board... ► Artikel lesen | ||||
| 26.06. | Oasmia Pharmaceutical AB: Oasmia presents full-year report and status in the Board's review through audiocast on June 28 | 4 | GlobeNewswire (Europe) | |
| Oasmia will hold an audiocast and telephone conference on Friday 28 June at 09:00 (CET) to present the company's full-year report for the financial year 2018/2019 and the status of the board's... ► Artikel lesen | ||||
| 25.06. | Oasmia Pharmaceutical AB - 6-K, Report of foreign issuer | 1 | SEC Filings | |
► Artikel lesen | ||||
| 25.06. | Oasmia Pharmaceutical AB: Two studies finalized in Oasmia Pharmaceutical's Docecal programme | 11 | GlobeNewswire (Europe) | |
| Oasmia Pharmaceutical AB (NASDAQ: OASM) reports on the results from the two clinical studies using Docecal in patients with metastatic breast cancer.
Docecal is a newly developed formulation... ► Artikel lesen | ||||
| 18.06. | Oasmia Pharmaceutical AB: Swedish Company Targeting Ovarian Cancer, But Doesn't Impress | 1 | Seeking Alpha | |
► Artikel lesen | ||||
| 20.05. | Oasmia Pharmaceutical AB - 6-K, Report of foreign issuer | 2 | SEC Filings | |
► Artikel lesen | ||||
| 15.05. | Oasmia Pharmaceutical AB: Oasmia postpones the release of the Q4 and year-end report to 28 June | 7 | GlobeNewswire (Europe) | |
| The Board of Oasmia has decided to postpone the release of the fourth quarter and year-end 2018/2019 report from 5 June 2019 to 28 June 2019. The delay is a result of the ongoing review initiated by... ► Artikel lesen | ||||
Seite:
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | |
|---|---|---|---|---|
| BAYER | 59,41 | +1,33 % | Bayer-Aktie: Milliardenwette auf den Krisenriesen | |
| von Sven Parplies, Euro am SonntagPaul Singer polarisiert. Für die einen ist der 74?Jahre alte Milliardär eine Investmentlegende, für andere ein skrupelloser Renditejäger. Bei Bayer wird man bald herausfinden... ► Artikel lesen | ||||
| NOVARTIS | 79,62 | +0,34 % | Der nächste Alzheimer-Rückschlag: Novartis und Amgen stellen Forschungsprojekt ein | |
| Schon wieder ein herber Rückschlag in der Alzheimer-Forschung. Diesmal traf es ein gemeinsames Forschungsprojekt (der BACE1-Inhibitor CNP520) der Schweizer mit Amgen und dem Banner Alzheimer Institut.... ► Artikel lesen | ||||
| NOVO NORDISK | 42,82 | +0,93 % | NOVO NORDISK A S - 6-K, Report of foreign issuer | |
► Artikel lesen | ||||
| MERCK KGAA | 92,64 | +0,35 % | Merck's Embracing Carers Launches 'Time Counts' to Raise 1 Million Minutes of Support for Carers | |
| - 'Time Counts' launches as a social media-led video series asking the global community to collectively give 1 million minutes to better support carers
- Embracing Carers, a global initiative... ► Artikel lesen | ||||
| PFIZER | 37,80 | +0,53 % | Pfizer steht vor dem Umsatzeinbruch - trotzdem solltest du die Aktie mögen | |
| Einige Investitionsentscheidungen scheinen echte Selbstläufer zu sein. Wenn man absehen kann, dass das Umsatzwachstum eines Unternehmens sinken wird, dann lässt man die Aktie lieber links liegen, oder?... ► Artikel lesen | ||||
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von
Nachrichten • Aktienkurse • DAX • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer | Datenschutz • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
